BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID of Ligand	PubChem SID of Ligand	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence	PDB ID(s) of Target Chain	UniProt (SwissProt) Recommended Name of Target Chain	UniProt (SwissProt) Entry Name of Target Chain	UniProt (SwissProt) Primary ID of Target Chain	UniProt (SwissProt) Secondary ID(s) of Target Chain	UniProt (SwissProt) Alternative ID(s) of Target Chain	UniProt (TrEMBL) Submitted Name of Target Chain	UniProt (TrEMBL) Entry Name of Target Chain	UniProt (TrEMBL) Primary ID of Target Chain	UniProt (TrEMBL) Secondary ID(s) of Target Chain	UniProt (TrEMBL) Alternative ID(s) of Target Chain
482825	CCCS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C19H17F2N7O2S/c1-2-8-31(29,30)28-13-6-5-12(20)16(14(13)21)27-18-11(4-3-7-22-18)15-17-19(25-9-23-15)26-10-24-17/h3-7,9-10,28H,2,8H2,1H3,(H,22,27)(H,23,24,25,26)	ZCFRMOFRDWXLRB-UHFFFAOYSA-N	197677	US9216981, 5::US9550781, 1	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=197677	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=197677&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			57344795	318488794							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482826	CCCS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]c(C)nc23)c1F	InChI=1S/C20H19F2N7O2S/c1-3-9-32(30,31)29-14-7-6-13(21)17(15(14)22)28-19-12(5-4-8-23-19)16-18-20(25-10-24-16)27-11(2)26-18/h4-8,10,29H,3,9H2,1-2H3,(H,23,28)(H,24,25,26,27)	JLKYLISKECNJKK-UHFFFAOYSA-N	205005	US9550781, 3::n-(2,4-difluoro-3-(3-(8-methyl-9h-purin-6-yl)pyridin-2-ylamino)phenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205005&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570422	375976930							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486919	CCc1ccc(nc1)C(=O)COc1ccc(CC2SC(=O)NC2=O)cc1	InChI=1S/C19H18N2O4S/c1-2-12-5-8-15(20-10-12)16(22)11-25-14-6-3-13(4-7-14)9-17-18(23)21-19(24)26-17/h3-8,10,17H,2,9,11H2,1H3,(H,21,23,24)	IRNJSRAGRIZIHD-UHFFFAOYSA-N	228129	US9562012, mitoglitazone	Nuclear receptor coactivator 2 [740-753]			 26600							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228129&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	LO7		89473459	375077072							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486920	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1	InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)	YASAKCUCGLMORW-UHFFFAOYSA-N	50030474	Avandamet::Avandaryl::Avandia::BRL-49653::CHEBI:50122::Rosiglitazone::US10744117, Compound Rosiglitazone::US9562012, rosiglitazone	Nuclear receptor coactivator 2 [740-753]			 125							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50030474	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50030474&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	BRL		77999	313065834			DB00412				1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486921	CCO[C@@H](Cc1ccc(OCc2ccccn2)cc1)C(=O)NO	InChI=1S/C17H20N2O4/c1-2-22-16(17(20)19-21)11-13-6-8-15(9-7-13)23-12-14-5-3-4-10-18-14/h3-10,16,21H,2,11-12H2,1H3,(H,19,20)/t16-/m0/s1	RTJDRHVEBDAEBC-INIZCTEOSA-N	228131	US9562012, 1::ethyl (2s)-2-ethoxy-3-(4-hydroxyphenyl)propanoate	Nuclear receptor coactivator 2 [740-753]			 58900							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228131&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473462	375077074							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486922	CCO[C@H](Cc1ccc(OC[C@@H](O)c2cccc(CO)c2)cc1)C(=O)NO	InChI=1S/C20H25NO6/c1-2-26-19(20(24)21-25)11-14-6-8-17(9-7-14)27-13-18(23)16-5-3-4-15(10-16)12-22/h3-10,18-19,22-23,25H,2,11-13H2,1H3,(H,21,24)/t18-,19-/m1/s1	QDBMIGAESBIPEL-RTBURBONSA-N	228132	US9562012, 2::ethyl (2r)-2-ethoxy-3-(4-hydroxyphenyl)propanoate	Nuclear receptor coactivator 2 [740-753]			>100000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228132&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473467	375077075							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486923	CCO[C@@H](Cc1ccc(OCc2cc(CO)ccn2)cc1)C(=O)NO	InChI=1S/C18H22N2O5/c1-2-24-17(18(22)20-23)10-13-3-5-16(6-4-13)25-12-15-9-14(11-21)7-8-19-15/h3-9,17,21,23H,2,10-12H2,1H3,(H,20,22)/t17-/m0/s1	AXSMDNDSPLOIEQ-KRWDZBQOSA-N	228133	(2s)-2-ethoxy-n-hydroxy-3-{4-[(3-iodobenzyl)oxy]phenyl}propanamide (compound no. 7)::US9562012, 3	Nuclear receptor coactivator 2 [740-753]			>250000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228133&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473468	375077076							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486924	CCO[C@@H](Cc1ccc(OCc2cc(CO)ccn2)cc1)C(=O)N(C)OC	InChI=1S/C20H26N2O5/c1-4-26-19(20(24)22(2)25-3)12-15-5-7-18(8-6-15)27-14-17-11-16(13-23)9-10-21-17/h5-11,19,23H,4,12-14H2,1-3H3/t19-/m0/s1	BELWYYNDXRZRPS-IBGZPJMESA-N	228134	US9562012, 4::ethyl (2s)-2-ethoxy-3-[4-(pyridin-2-ylmethoxy)phenyl]propanoate	Nuclear receptor coactivator 2 [740-753]			 27700							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228134&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473461	375077077							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486925	CCO[C@@H](Cc1ccc(OCc2cc(CO)ccn2)cc1)C(=O)NOC	InChI=1S/C19H24N2O5/c1-3-25-18(19(23)21-24-2)11-14-4-6-17(7-5-14)26-13-16-10-15(12-22)8-9-20-16/h4-10,18,22H,3,11-13H2,1-2H3,(H,21,23)/t18-/m0/s1	OLJTWKWUGLQEKK-SFHVURJKSA-N	228135	(2s)-2-ethoxy-n-hydroxy-3-[4-(pyridin-2-ylmethoxy)phenyl]propanamide hydrogen chloride (compound no. 1)::US9562012, 5	Nuclear receptor coactivator 2 [740-753]			>250000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228135&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473752	375077078							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486926	CCO[C@@H](Cc1ccc(OCc2cc(CO)ccn2)cc1)C(=O)N(C)O	InChI=1S/C19H24N2O5/c1-3-25-18(19(23)21(2)24)11-14-4-6-17(7-5-14)26-13-16-10-15(12-22)8-9-20-16/h4-10,18,22,24H,3,11-13H2,1-2H3/t18-/m0/s1	OWDAHMWDQVALSC-SFHVURJKSA-N	228136	US9562012, 6::ethyl (2s)-2-ethoxy-3-{4-[(4-methoxypyridin-2-yl)methoxy]phenyl}propanoate	Nuclear receptor coactivator 2 [740-753]			>195000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228136&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473751	375077079							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486927	CCO[C@@H](Cc1ccc(OCc2cccc(I)c2)cc1)C(=O)NO	InChI=1S/C18H20INO4/c1-2-23-17(18(21)20-22)11-13-6-8-16(9-7-13)24-12-14-4-3-5-15(19)10-14/h3-10,17,22H,2,11-12H2,1H3,(H,20,21)/t17-/m0/s1	KUDCLQGQSKZWMM-KRWDZBQOSA-N	228137	(2s)-2-ethoxy-3-{4-[(4-methoxypyridin-2-yl)methoxy]phenyl}propanoic acid hydrochloride::US9562012, 7	Nuclear receptor coactivator 2 [740-753]			 11800							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228137&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473759	375077080							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486928	CCO[C@H](Cc1ccc(OCC(=O)c2cccc(CO)c2)cc1)C(=O)NOC	InChI=1S/C21H25NO6/c1-3-27-20(21(25)22-26-2)12-15-7-9-18(10-8-15)28-14-19(24)17-6-4-5-16(11-17)13-23/h4-11,20,23H,3,12-14H2,1-2H3,(H,22,25)/t20-/m1/s1	CCSCSONTXSLLLG-HXUWFJFHSA-N	228138	(2s)-2-ethoxy-n-hydroxy-3-{4-[(4-methoxypyridin-2-yl)methoxy]phenyl}propanamide hydrochloride (compound no. 3)::US9562012, 8	Nuclear receptor coactivator 2 [740-753]			 98500							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228138&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473749	375077081							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486929	CCO[C@@H](Cc1ccc(OCc2ccc(cc2)S(C)(=O)=O)cc1)C(=O)NOC	InChI=1S/C20H25NO6S/c1-4-26-19(20(22)21-25-2)13-15-5-9-17(10-6-15)27-14-16-7-11-18(12-8-16)28(3,23)24/h5-12,19H,4,13-14H2,1-3H3,(H,21,22)/t19-/m0/s1	ZAGFHWXPZRSKET-IBGZPJMESA-N	228139	(2s)-2-ethoxy-n-methoxy-3-{4-[(4-methoxypyridin-2-yl)methoxy]phenyl}-n-methylpropanamide (compound no. 4)::US9562012, 9	Nuclear receptor coactivator 2 [740-753]			>250000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228139&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89462750	375077082							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486930	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)NOC	InChI=1S/C21H27NO7S/c1-4-27-20(21(23)22-26-2)15-17-7-9-18(10-8-17)28-14-13-16-5-11-19(12-6-16)29-30(3,24)25/h5-12,20H,4,13-15H2,1-3H3,(H,22,23)/t20-/m0/s1	AMMVQSNUNXRUFR-FQEVSTJZSA-N	228140	(2s)-2-ethoxy-n-methoxy-3-{4-[(4-methoxypyridin-2-yl)methoxy]phenyl}propanamide hydrochloride (compound no. 5)::US9562012, 10	Nuclear receptor coactivator 2 [740-753]			 7900							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228140&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473753	375077083							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486931	CCO[C@H](Cc1ccc(OCC(=O)c2cccc(CO)c2)cc1)C(=O)N(C)OC	InChI=1S/C22H27NO6/c1-4-28-21(22(26)23(2)27-3)13-16-8-10-19(11-9-16)29-15-20(25)18-7-5-6-17(12-18)14-24/h5-12,21,24H,4,13-15H2,1-3H3/t21-/m1/s1	PGHBRJMNCXCVBI-OAQYLSRUSA-N	228141	(2s)-2-ethoxy-n-hydroxy-3-{4-[(4-methoxypyridin-2-yl)methoxy]phenyl}-n-methylpropanamide hydrochloride (compound no. 6)::US9562012, 11	Nuclear receptor coactivator 2 [740-753]			 30500							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228141&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473638	375077084							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486932	CCO[C@@H](Cc1ccc(OC[C@@H](O)c2cccc(CO)c2)cc1)C(=O)NOC	InChI=1S/C21H27NO6/c1-3-27-20(21(25)22-26-2)12-15-7-9-18(10-8-15)28-14-19(24)17-6-4-5-16(11-17)13-23/h4-11,19-20,23-24H,3,12-14H2,1-2H3,(H,22,25)/t19-,20+/m1/s1	MOCRSZLHEHJVTG-UXHICEINSA-N	228142	US9562012, 12::ethyl (2r)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl}propanoate	Nuclear receptor coactivator 2 [740-753]			 164300							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228142&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473636	375077085							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486933	CCO[C@@H](Cc1ccc(OCC(=O)c2cccc(CO)c2)cc1)C(=O)NOC	InChI=1S/C21H25NO6/c1-3-27-20(21(25)22-26-2)12-15-7-9-18(10-8-15)28-14-19(24)17-6-4-5-16(11-17)13-23/h4-11,20,23H,3,12-14H2,1-2H3,(H,22,25)/t20-/m0/s1	CCSCSONTXSLLLG-FQEVSTJZSA-N	228143	(2r)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl}propanoic acid::US9562012, 13	Nuclear receptor coactivator 2 [740-753]			 61400							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228143&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89462654	375077086							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486934	CCO[C@@H](Cc1ccc(OCC(=O)c2cccc(CO)c2)cc1)C(=O)N(C)OC	InChI=1S/C22H27NO6/c1-4-28-21(22(26)23(2)27-3)13-16-8-10-19(11-9-16)29-15-20(25)18-7-5-6-17(12-18)14-24/h5-12,21,24H,4,13-15H2,1-3H3/t21-/m0/s1	PGHBRJMNCXCVBI-NRFANRHFSA-N	228144	(2r)-2-ethoxy-n-methoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl}propanamide (compound no. 8)::US9562012, 14	Nuclear receptor coactivator 2 [740-753]			>250000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228144&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89462480	375077087							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486935	CCO[C@@H](Cc1ccc(OC[C@H](O)c2cccc(CO)c2)cc1)C(=O)NOC	InChI=1S/C21H27NO6/c1-3-27-20(21(25)22-26-2)12-15-7-9-18(10-8-15)28-14-19(24)17-6-4-5-16(11-17)13-23/h4-11,19-20,23-24H,3,12-14H2,1-2H3,(H,22,25)/t19-,20-/m0/s1	MOCRSZLHEHJVTG-PMACEKPBSA-N	228145	(2r)-2-ethoxy-n-methoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl}-n-methylpropanamide (compound no. 11)::US9562012, 15	Nuclear receptor coactivator 2 [740-753]			>200000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228145&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473637	375077088							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486936	CCO[C@@H](Cc1ccc(OC[C@H](O)c2cccc(CO)c2)cc1)C(=O)N(C)OC	InChI=1S/C22H29NO6/c1-4-28-21(22(26)23(2)27-3)13-16-8-10-19(11-9-16)29-15-20(25)18-7-5-6-17(12-18)14-24/h5-12,20-21,24-25H,4,13-15H2,1-3H3/t20-,21-/m0/s1	FJXWUXJKXXSRCI-SFTDATJTSA-N	228146	(2r)-2-ethoxy-3-{4-[(2s)-2-hydroxy-2-(3-methoxyphenyl)ethoxy]phenyl}-n-methoxypropanamide (compound no. 18)::US9562012, 16	Nuclear receptor coactivator 2 [740-753]			 190800							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228146&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473640	375077089							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486937	CCO[C@@H](Cc1ccc(OC[C@@H](O)c2cccc(CO)c2)cc1)C(=O)N(C)OC	InChI=1S/C22H29NO6/c1-4-28-21(22(26)23(2)27-3)13-16-8-10-19(11-9-16)29-15-20(25)18-7-5-6-17(12-18)14-24/h5-12,20-21,24-25H,4,13-15H2,1-3H3/t20-,21+/m1/s1	FJXWUXJKXXSRCI-RTWAWAEBSA-N	228147	US9562012, 17::ethyl (2r)-2-ethoxy-3-{4-[(2s)-2-hydroxy-2-(3-methoxyphenyl)ethoxy]phenyl}propanoate	Nuclear receptor coactivator 2 [740-753]			 27700							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228147&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473639	375077090							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486938	CCO[C@H](Cc1ccc(OC[C@@H](O)c2cccc(CO)c2)cc1)C(=O)NOC	InChI=1S/C21H27NO6/c1-3-27-20(21(25)22-26-2)12-15-7-9-18(10-8-15)28-14-19(24)17-6-4-5-16(11-17)13-23/h4-11,19-20,23-24H,3,12-14H2,1-2H3,(H,22,25)/t19-,20-/m1/s1	MOCRSZLHEHJVTG-WOJBJXKFSA-N	228148	(2r)-2-ethoxy-n-hydroxy-3-{4-[(2s)-2-hydroxy-2-(3-methoxyphenyl)ethoxy]phenyl}propanamide (compound no. 2)::US9562012, 18	Nuclear receptor coactivator 2 [740-753]			>250000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228148&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473570	375077091							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486939	CCO[C@H](Cc1ccc(OC[C@H](O)c2cccc(CO)c2)cc1)C(=O)NOC	InChI=1S/C21H27NO6/c1-3-27-20(21(25)22-26-2)12-15-7-9-18(10-8-15)28-14-19(24)17-6-4-5-16(11-17)13-23/h4-11,19-20,23-24H,3,12-14H2,1-2H3,(H,22,25)/t19-,20+/m0/s1	MOCRSZLHEHJVTG-VQTJNVASSA-N	228149	(2r)-2-ethoxy-3-{4-[(2r)-2-hydroxy-2-(3-methoxyphenyl)ethoxy]phenyl}-n-methoxypropanamide (compound no. 19)::US9562012, 19	Nuclear receptor coactivator 2 [740-753]			>250000							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228149&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473567	375077092							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486940	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)N(C)O	InChI=1S/C21H27NO7S/c1-4-27-20(21(23)22(2)24)15-17-7-9-18(10-8-17)28-14-13-16-5-11-19(12-6-16)29-30(3,25)26/h5-12,20,24H,4,13-15H2,1-3H3/t20-/m0/s1	WVHUJKXLKUVSBG-FQEVSTJZSA-N	228150	US9562012, 20::ethyl (2s)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl}propanoate	Nuclear receptor coactivator 2 [740-753]			 10900							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228150&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473571	375077093							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
486941	CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)N(C)OC	InChI=1S/C22H29NO7S/c1-5-28-21(22(24)23(2)27-3)16-18-8-10-19(11-9-18)29-15-14-17-6-12-20(13-7-17)30-31(4,25)26/h6-13,21H,5,14-16H2,1-4H3/t21-/m0/s1	OJUXYDSDHTUKMW-NRFANRHFSA-N	228151	(2s)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl}propanoic acid::US9562012, 21	Nuclear receptor coactivator 2 [740-753]			 3700							US Patent		10.7270/Q26H4KDK		aid1795125	US9562012	Tanis, SP; Larsen, SD; Artman, III, GD; Parker, T	Metabolic Solutions Development Company, LLC	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=228151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=228151&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			89473568	375077094							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482827	CCCS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1	InChI=1S/C19H18FN7O2S/c1-2-8-30(28,29)27-12-5-6-14(20)15(9-12)26-18-13(4-3-7-21-18)16-17-19(24-10-22-16)25-11-23-17/h3-7,9-11,27H,2,8H2,1H3,(H,21,26)(H,22,23,24,25)	ZCXUPOGJVWSIFV-UHFFFAOYSA-N	205007	US9550781, 4::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-fluorophenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205007&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570423	375976931							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482828	CCCS(=O)(=O)Nc1ccc(Cl)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1	InChI=1S/C19H18ClN7O2S/c1-2-8-30(28,29)27-12-5-6-14(20)15(9-12)26-18-13(4-3-7-21-18)16-17-19(24-10-22-16)25-11-23-17/h3-7,9-11,27H,2,8H2,1H3,(H,21,26)(H,22,23,24,25)	CUVTVXCACUQQKZ-UHFFFAOYSA-N	205008	US9550781, 5::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-chlorophenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205008&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570424	375976932							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482829	CCCS(=O)(=O)Nc1ccc(C)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1	InChI=1S/C20H21N7O2S/c1-3-9-30(28,29)27-14-7-6-13(2)16(10-14)26-19-15(5-4-8-21-19)17-18-20(24-11-22-17)25-12-23-18/h4-8,10-12,27H,3,9H2,1-2H3,(H,21,26)(H,22,23,24,25)	RQBYBLUJOBQVIL-UHFFFAOYSA-N	205009	US9550781, 6::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-methylphenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205009&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570425	375976933							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482830	CCCS(=O)(=O)Nc1ccc(Cl)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C19H17ClFN7O2S/c1-2-8-31(29,30)28-13-6-5-12(20)16(14(13)21)27-18-11(4-3-7-22-18)15-17-19(25-9-23-15)26-10-24-17/h3-7,9-10,28H,2,8H2,1H3,(H,22,27)(H,23,24,25,26)	CTFMLBPOJGBVKC-UHFFFAOYSA-N	205010	US9550781, 7::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-chloro-2-fluorophenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205010&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570718	375976934							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482831	CCCS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1Cl	InChI=1S/C19H17ClFN7O2S/c1-2-8-31(29,30)28-13-6-5-12(21)16(14(13)20)27-18-11(4-3-7-22-18)15-17-19(25-9-23-15)26-10-24-17/h3-7,9-10,28H,2,8H2,1H3,(H,22,27)(H,23,24,25,26)	HEQIVWNUOHTHMI-UHFFFAOYSA-N	205011	US9550781, 8::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2-chloro-4-fluorophenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205011&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570568	375976935							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482832	FCCCS(=O)(=O)Nc1ccc(Cl)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C19H16ClF2N7O2S/c20-12-4-5-13(29-32(30,31)8-2-6-21)14(22)16(12)28-18-11(3-1-7-23-18)15-17-19(26-9-24-15)27-10-25-17/h1,3-5,7,9-10,29H,2,6,8H2,(H,23,28)(H,24,25,26,27)	POUWGNJQCLRYDF-UHFFFAOYSA-N	205012	US9550781, 9::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-4-chloro-2-fluorophenyl)-3-fluoropropane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205012&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570569	375976936							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482833	FCCCS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C19H16F3N7O2S/c20-6-2-8-32(30,31)29-13-5-4-12(21)16(14(13)22)28-18-11(3-1-7-23-18)15-17-19(26-9-24-15)27-10-25-17/h1,3-5,7,9-10,29H,2,6,8H2,(H,23,28)(H,24,25,26,27)	DHMVFLJXLIVNOW-UHFFFAOYSA-N	205013	US9550781, 10::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)-3-fluoropropane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205013&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570570	375976937							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482834	Fc1ccc(NS(=O)(=O)CCl)c(F)c1Nc1ncccc1-c1ncnc2[nH]cnc12	InChI=1S/C17H12ClF2N7O2S/c18-6-30(28,29)27-11-4-3-10(19)14(12(11)20)26-16-9(2-1-5-21-16)13-15-17(24-7-22-13)25-8-23-15/h1-5,7-8,27H,6H2,(H,21,26)(H,22,23,24,25)	LJDVFTJHWFFLBG-UHFFFAOYSA-N	205014	US9550781, 11::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)-1-chloromethanesulfonamide	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205014&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570571	375976938							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482835	CCS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C18H15F2N7O2S/c1-2-30(28,29)27-12-6-5-11(19)15(13(12)20)26-17-10(4-3-7-21-17)14-16-18(24-8-22-14)25-9-23-16/h3-9,27H,2H2,1H3,(H,21,26)(H,22,23,24,25)	SJTSXGWSETUPIF-UHFFFAOYSA-N	205015	US9550781, 12::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)ethanesulfonamide	Nuclear receptor coactivator 2 [740-753]			<1000							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205015&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570572	375976939							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482836	CS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C17H13F2N7O2S/c1-29(27,28)26-11-5-4-10(18)14(12(11)19)25-16-9(3-2-6-20-16)13-15-17(23-7-21-13)24-8-22-15/h2-8,26H,1H3,(H,20,25)(H,21,22,23,24)	WCNKFDYACPTVPO-UHFFFAOYSA-N	50165871	CHEMBL3798635::US9550781, 13	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50165871	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50165871&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570573	341097721		CHEMBL3798635					1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482837	Fc1ccc(cc1F)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C22H13F4N7O2S/c23-13-4-3-11(8-15(13)25)36(34,35)33-16-6-5-14(24)19(17(16)26)32-21-12(2-1-7-27-21)18-20-22(30-9-28-18)31-10-29-20/h1-10,33H,(H,27,32)(H,28,29,30,31)	FSBHALPDNFWYRZ-UHFFFAOYSA-N	205017	US9550781, 14::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)-3,4-difluorobenzenesulfonamide	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205017&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570719	375976941							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482838	Fc1ccc(NS(=O)(=O)c2ccccc2)c(F)c1Nc1ncccc1-c1ncnc2[nH]cnc12	InChI=1S/C22H15F2N7O2S/c23-15-8-9-16(31-34(32,33)13-5-2-1-3-6-13)17(24)19(15)30-21-14(7-4-10-25-21)18-20-22(28-11-26-18)29-12-27-20/h1-12,31H,(H,25,30)(H,26,27,28,29)	UHPAFPKCOMSYMO-UHFFFAOYSA-N	197706	US9216981, 35::US9550781, 15	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=197706	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=197706&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			57343766	318488823							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482839	Fc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(F)c1Nc1ncccc1-c1ncnc2[nH]cnc12	InChI=1S/C22H14ClF2N7O2S/c23-12-3-5-13(6-4-12)35(33,34)32-16-8-7-15(24)19(17(16)25)31-21-14(2-1-9-26-21)18-20-22(29-10-27-18)30-11-28-20/h1-11,32H,(H,26,31)(H,27,28,29,30)	LRPFEAFWFAJAGS-UHFFFAOYSA-N	205020	US9550781, 17::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)-4-chlorobenzenesulfonamide	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205020&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570720	375976943							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482840	Fc1ccc(NS(=O)(=O)CCC(F)(F)F)c(F)c1Nc1ncccc1-c1ncnc2[nH]cnc12	InChI=1S/C19H14F5N7O2S/c20-11-3-4-12(31-34(32,33)7-5-19(22,23)24)13(21)15(11)30-17-10(2-1-6-25-17)14-16-18(28-8-26-14)29-9-27-16/h1-4,6,8-9,31H,5,7H2,(H,25,30)(H,26,27,28,29)	RVZIFRBRTJZNQB-UHFFFAOYSA-N	205021	US9550781, 18::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)-3,3,3-trifluoropropane-1-sulfon amide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205021&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570721	375976944							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482841	Fc1ccc(NS(=O)(=O)CC(F)(F)F)c(F)c1Nc1ncccc1-c1ncnc2[nH]cnc12	InChI=1S/C18H12F5N7O2S/c19-10-3-4-11(30-33(31,32)6-18(21,22)23)12(20)14(10)29-16-9(2-1-5-24-16)13-15-17(27-7-25-13)28-8-26-15/h1-5,7-8,30H,6H2,(H,24,29)(H,25,26,27,28)	PWEHFDUGZVTNNL-UHFFFAOYSA-N	50165873	CHEMBL3800014::US9550781, 19	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50165873	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50165873&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570722	341097722		CHEMBL3800014					1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482842	Fc1ccc(NS(=O)(=O)C=C)c(F)c1Nc1ncccc1-c1ncnc2[nH]cnc12	InChI=1S/C18H13F2N7O2S/c1-2-30(28,29)27-12-6-5-11(19)15(13(12)20)26-17-10(4-3-7-21-17)14-16-18(24-8-22-14)25-9-23-16/h2-9,27H,1H2,(H,21,26)(H,22,23,24,25)	VFBJLLKJJMEGRT-UHFFFAOYSA-N	205023	US9550781, 20::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)ethenesulfonamide	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205023&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570723	375976946							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482843	Fc1ccc(NS(=O)(=O)C2CC2c2ccccc2)c(F)c1Nc1ncccc1-c1ncnc2[nH]cnc12			205024	US9550781, 21::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)-2-phenylcyclopropane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205024&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71571012	375976947							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482844	COc1ccc(cc1)C1CC1S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F			205025	US9550781, 22::n-(3-(3-(9h-purin-6-yl)pyridin-2-ylamino)-2,4-difluorophenyl)-2-(4-methoxyphenyl)cyclopropane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<1000							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205025&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570865	375976948							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482845	Fc1ccc(cc1)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C22H14F3N7O2S/c23-12-3-5-13(6-4-12)35(33,34)32-16-8-7-15(24)19(17(16)25)31-21-14(2-1-9-26-21)18-20-22(29-10-27-18)30-11-28-20/h1-11,32H,(H,26,31)(H,27,28,29,30)	HWTHWPBGOLUDQA-UHFFFAOYSA-N	50165865	CHEMBL3798423::US9550781, 23	Nuclear receptor coactivator 2 [740-753]			<1000							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50165865	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50165865&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570866	341097717		CHEMBL3798423					1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482846	Fc1ccc(NS(=O)(=O)c2ccsc2)c(F)c1Nc1ncccc1-c1ncnc2[nH]cnc12	InChI=1S/C20H13F2N7O2S2/c21-13-3-4-14(29-33(30,31)11-5-7-32-8-11)15(22)17(13)28-19-12(2-1-6-23-19)16-18-20(26-9-24-16)27-10-25-18/h1-10,29H,(H,23,28)(H,24,25,26,27)	YSBVTNXKLLPITL-UHFFFAOYSA-N	197689	US9216981, 17::US9550781, 24	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=197689	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=197689&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			57345094	318488806							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482847	CCCS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]ncc23)c1F	InChI=1S/C19H17F2N7O2S/c1-2-8-31(29,30)28-14-6-5-13(20)17(15(14)21)26-18-11(4-3-7-22-18)16-12-9-25-27-19(12)24-10-23-16/h3-7,9-10,28H,2,8H2,1H3,(H,22,26)(H,23,24,25,27)	MNWBOFLYTZMCCB-UHFFFAOYSA-N	205035	US9550781, 25::n-(3-(3-(1h-pyrazolo[3,4-d]pyrimidin-4-yl)pyridin-2-ylamino)-2,4-difluorophenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205035&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570867	375976951							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482848	CCCS(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]ccc23)c1F	InChI=1S/C20H18F2N6O2S/c1-2-10-31(29,30)28-15-6-5-14(21)18(16(15)22)27-20-12(4-3-8-23-20)17-13-7-9-24-19(13)26-11-25-17/h3-9,11,28H,2,10H2,1H3,(H,23,27)(H,24,25,26)	FEEUFPDYGNYMHA-UHFFFAOYSA-N	205038	US9550781, 26::n-(3-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyridin-2-ylamino)-2,4-difluorophenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<500							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205038&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71570868	375976952							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482849	CCCS(=O)(=O)Nc1ccc(C)c(Nc2ccccc2-c2ncnc3[nH]cnc23)c1	InChI=1S/C21H22N6O2S/c1-3-10-30(28,29)27-15-9-8-14(2)18(11-15)26-17-7-5-4-6-16(17)19-20-21(24-12-22-19)25-13-23-20/h4-9,11-13,26-27H,3,10H2,1-2H3,(H,22,23,24,25)	CVRWXYFNDBMPRI-UHFFFAOYSA-N	205040	US9550781, 27::n-(3-(2-(9h-purin-6-yl)phenylamino)-4-methylphenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<100.0							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205040&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71571014	375976953							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
482850	CCCS(=O)(=O)Nc1ccc(F)c(Nc2ccccc2-c2ncnc3[nH]cnc23)c1F	InChI=1S/C20H18F2N6O2S/c1-2-9-31(29,30)28-15-8-7-13(21)18(16(15)22)27-14-6-4-3-5-12(14)17-19-20(25-10-23-17)26-11-24-19/h3-8,10-11,27-28H,2,9H2,1H3,(H,23,24,25,26)	PDRREFGANPRKJD-UHFFFAOYSA-N	205042	US9550781, 28::n-(3-(2-(9h-purin-6-yl)phenylamino)-2,4-difluorophenyl)propane-1-sulfonamide	Nuclear receptor coactivator 2 [740-753]			<1000							US Patent		10.7270/Q2X63PXK		aid1795097	US9550781	Xiao, D; Li, J; Zhu, Y; Hu, Y; Wang, H; Wang, Z; Wang, Z; Wei, Y; Sun, Y; Wu, Q; Zhang, H; Peng, Y; Kong, F; Sun, Y; Luo, H; Han, Y	Centaurus BioPharma Co., Ltd	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=205042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4349&target=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=205042&enzyme=Nuclear+receptor+coactivator+2+%5B740-753%5D&column=ki&startPg=0&Increment=50&submit=Search			71571013	375976954							1	KENALLRYLLDKDD		Nuclear receptor coactivator 2	NCOA2_HUMAN	Q15596	Q14CD2						
